NCT06775223

Brief Summary

Cardiac implantable electronic devices are widely utilized to lower the rates of morbidity and mortality from ventricular tachycardia and ventricular fibrillation, as well as the incidence of sudden cardiac death. Although implantation of these devices increases survival rates, patients may experience acute and chronic complications. These complications include device dislocation and fracture, inappropriate shocks, pocket hematoma, or infection. Furthermore, functional loss in the upper extremity may result from upper extremity restrictions that are applied for an excessively long time in order to ensure proper placement of the device following implantation, or from patients who choose to extend this period on their own initiative out of worry about device failure or dislocation. Patients' quality of life may be negatively impacted by these issues as well as diminished exercise capacity, weariness, and weaker respiratory and peripheral muscles. A quality of life scale called 'The Assessment of Quality of Life and Related Events (AQUAREL)' was developed by Stoffmel et al. for patients using pacemakers. In this study, the validity and reliability study of the Turkish version of the AQAREL Scale will be conducted.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 5, 2024

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 10, 2024

Completed
4 months until next milestone

First Posted

Study publicly available on registry

January 15, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

January 15, 2025

Status Verified

January 1, 2025

Enrollment Period

12 months

First QC Date

September 10, 2024

Last Update Submit

January 9, 2025

Conditions

Keywords

quality of lifepatient reported outcomescardiac implantable electronic devices

Outcome Measures

Primary Outcomes (1)

  • Turkish adaptation of the scale assessing quality of life

    The Assessment of Quality of Life And RELated Events (AQUAREL) scale, which was created especially for people with cardiac implanted electronic devices, will be translated into Turkish. / The total score ranges from 0 to 100. A low score reflects poor health perception, loss of function and presence of pain, while a high score reflects good health perception, preserved function and absence of pain.

    1 years

Secondary Outcomes (4)

  • Evaluation of quality of life

    1 year

  • Evaluation of quality of life

    1 year

  • Evaluation of activities of daily living

    1 year

  • Evaluation of comorbidity level

    1 year

Interventions

validity and reliability study

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

participant with cardiac implantable electronic devices between the ages of 18-65

You may qualify if:

  • Having a pacemaker implant and not having any complications at the last pacemaker check-up,
  • Being in NYHA I-II-III-IV class,
  • Patients with no cooperation problems,
  • Volunteering to participate in the study.

You may not qualify if:

  • Patients with insufficient dementia or cognitive impairment due to multiple comorbidities (e.g., recent cerebrovascular accident and/or significant hypotension),
  • Patients with a history of psychiatric illness,
  • Patients with speech, hearing or intellectual disabilities.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hitit University Corum Erol Olçok Training and Research Hospital

Çorum, Center, 19000, Turkey (Türkiye)

RECRUITING

Central Study Contacts

GAMZE NUR AHISKALI, MsC

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Physiotherapist Gamze Nur AHISKALI

Study Record Dates

First Submitted

September 10, 2024

First Posted

January 15, 2025

Study Start

June 5, 2024

Primary Completion

June 1, 2025

Study Completion

June 1, 2025

Last Updated

January 15, 2025

Record last verified: 2025-01

Data Sharing

IPD Sharing
Will not share

Locations